Clinical Support

CKD progression

Studies of plasma biomarkers for CKD progression

READ STUDIES

KidneyIntelX

Studies supporting utility and impact of KidneyIntelX

READ STUDIES

FractalDx

Studies supporting utility and impact of FractalDx

READ STUDIES
30Jun

Partnership with the University of Michigan to extend KidneyIntelX™ use to broad CKD populations & Data sharing agreement with a top ten global pharmaceutical company

Renalytix AI plc announces a partnership with the University of Michigan (“UM”) to extend the application of the KidneyIntelX™ platform .. Read More →
25Jun

Public filing of registration statement with SEC for a proposed Nasdaq dual-listing and global offering

Renalytix AI plc announces the public filing of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission.. Read More →

Join our
Investor Newsletter